| 000 | 01148 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250516003656.0 | ||
| 264 | 0 | _c20110210 | |
| 008 | 201102s 0 0 eng d | ||
| 022 | _a1875-6697 | ||
| 024 | 7 |
_a10.2174/1573409911006040252 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGálvez, J | |
| 245 | 0 | 0 |
_aOn the contribution of molecular topology to drug design and discovery. _h[electronic resource] |
| 260 |
_bCurrent computer-aided drug design _cDec 2010 |
||
| 300 |
_a252-68 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aComputer Simulation |
| 650 | 0 | 4 | _aComputer-Aided Design |
| 650 | 0 | 4 | _aDrug Design |
| 650 | 0 | 4 |
_aDrug Discovery _xmethods |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aModels, Molecular |
| 650 | 0 | 4 |
_aPharmaceutical Preparations _xchemistry |
| 650 | 0 | 4 | _aQuantitative Structure-Activity Relationship |
| 700 | 1 | _aGarcía-Doménech, R | |
| 773 | 0 |
_tCurrent computer-aided drug design _gvol. 6 _gno. 4 _gp. 252-68 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2174/1573409911006040252 _zAvailable from publisher's website |
| 999 |
_c20211450 _d20211450 |
||